Convalescent plasma in COVID-19: renewed focus on the timing and effectiveness of an old therapy

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the coronavirus disease 2019 (COVID-19) pandemic that has strained health care systems worldwide and resulted in high mortality. The current COVID-19 treatment is based on supportive and symptomatic care. Therefore, conv...

Descripción completa

Detalles Bibliográficos
Autores principales: Nashaat, Hebat-Allah Hassan, Anani, Maha, Attia, Fadia M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8958377/
https://www.ncbi.nlm.nih.gov/pubmed/35197369
http://dx.doi.org/10.5045/br.2021.2021151

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8958377/
https://www.ncbi.nlm.nih.gov/pubmed/35197369
http://dx.doi.org/10.5045/br.2021.2021151

Ejemplares similares